PACLITAXEL Side Effects

6818730-0 | Acute Coronary Syndrome, Blood Pressure Diastolic Decreased, Coronary Artery Stenosis, Emotional Distress
on Jun 15, 2010 Female patient from TURKEY , 51 years of age, was diagnosed with ovarian cancer and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, blood pressure diastolic decreased, coronary artery stenosis, emotional distress. Paclitaxel dosage: Iv. During the same period patient was treated with DEXAMETHASONE (PREV.) (View Dexamethasone (prev.) Review and Dexamethasone (prev.) Label ), RANITIDINE (PREV.) (View Ranitidine (prev.) Review and Ranitidine (prev.) Label ), GRANISETRON (PREV.) (View Granisetron (prev.) Review and Granisetron (prev.) Label ), PHENIRAMINE (PREV.) (View Pheniramine (prev.) Review and Pheniramine (prev.) Label ). Patient was hospitalized.

6818614-8 | Facial Palsy, Neuropathy Peripheral
Patient was taking Paclitaxel (View Usage). Patient had the following side effects: facial palsy, neuropathy peripheral on Jun 21, 2010 from IRAN (ISLAMIC REPUBLIC OF) Additional patient health information: Female patient , 56 years of age, was diagnosed with ovarian epithelial cancer stage iii and. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6816119-1 | Chest Pain, Dyspnoea, Infusion Related Reaction
Adverse event was reported on Jul 02, 2010 by a Male patient taking Paclitaxel (View Usage) (Dosage: 372 Mg Once Iv) . Location: UNITED STATES , 60 years of age, After Paclitaxel was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea, infusion related reaction. Patient was hospitalized.

6815306-6 | Failure To Thrive, Pneumothorax
on Jun 29, 2010 Male patient from UNITED STATES , 64 years of age, weighting 112.4 lb, was diagnosed with non-small cell lung cancer, insomnia, constipation (What is constipation?), hypercholesterolaemia, dyspnoea, cough, pain (What is pain?) and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: failure to thrive, pneumothorax. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), DOCUSATE SODIUM (1 Df - 100-200mg) (View Docusate Sodium Review and Docusate Sodium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ALBUTEROL (2 Df - 2puffs) (View Albuterol Review and Albuterol Label ), TYLOX (1 Df - 5/325mg) (View Tylox Review and Tylox Label ). Patient was hospitalized.


6798252-6 | Atelectasis, Dyspnoea, Hypotension, Lung Consolidation, Sepsis, Tachycardia, Tumour Lysis Syndrome
on Jun 07, 2010 Female patient from UNITED STATES , 60 years of age, was diagnosed with endometrial cancer recurrent and was treated with Paclitaxel (View Usage). Patient had the following side effects: atelectasis, dyspnoea, hypotension, lung consolidation, sepsis (What is sepsis?), tachycardia, tumour lysis syndrome. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6796357-7 | Bronchospasm, Chest Pain, Tachycardia
Patient was taking Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: bronchospasm, chest pain (What is chest pain?), tachycardia on Jun 15, 2010 from SPAIN Additional patient health information: Male patient , 51 years of age, . Paclitaxel dosage: 1 Cycle, Intravenous. During the same period patient was treated with (POLARAMINE /00043702/) (View (polaramine /00043702/) Review and (polaramine /00043702/) Label ), (DECADARN /00016002/) (View (decadarn /00016002/) Review and (decadarn /00016002/) Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

6794753-5 | Cardio-respiratory Arrest, Myocardial Infarction
Adverse event was reported on Jun 21, 2010 by a Male patient taking Paclitaxel (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer, hypertension, back pain (What is back pain?), seasonal allergy and. Location: UNITED STATES , 71 years of age, weighting 350.5 lb, Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, myocardial infarction. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), COREG (View Coreg Review and Coreg Label ), PERCOCET (View Percocet Review and Percocet Label ), VALIUM (View Valium Review and Valium Label ), NORCO (View Norco Review and Norco Label ), SINGULAIR (View Singulair Review and Singulair Label ), K DUR (View K-dur Review and K-dur Label ).

6791057-1 | Oesophagitis
on Jun 21, 2010 Male patient from GERMANY , 68 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer, chronic obstructive pulmonary disease and was treated with Paclitaxel (View Usage). Patient had the following side effects: oesophagitis. Paclitaxel dosage: Recent Infusion On 2mar10. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), VINORELBINE (View Vinorelbine Review and Vinorelbine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

6790265-3 | Blood Creatinine Increased, Hyperglycaemia
on Jun 21, 2010 Male patient from SPAIN , 77 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: blood creatinine increased, hyperglycaemia. Paclitaxel dosage: 1104mg,3cycle:last Cycle:31may2006. During the same period patient was treated with CARBOPLATIN (1413mg,3cycle:last Cycle:31may2006) (View Carboplatin Review and Carboplatin Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), MORPHINE (View Morphine Review and Morphine Label ), DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

6786969-9 | Cyanosis, Dyspnoea, Eye Rolling, Loss Of Consciousness
Patient was taking Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: cyanosis, dyspnoea, eye rolling, loss of consciousness on Jun 03, 2010 from PHILIPPINES Additional patient health information: Female patient , 36 years of age, was diagnosed with lung adenocarcinoma and. Paclitaxel dosage: (175 Mg/m2, 2x100mg+30 Mg), Intravenous (not Otherwise Specified).

6784538-8 | Arterial Thrombosis
Adverse event was reported on Jun 15, 2010 by a Male patient taking Paclitaxel (View Usage) (Dosage: ) was diagnosed with gastric cancer and. Location: JAPAN , 69 years of age, Patient had the following side effects: arterial thrombosis. During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6774736-1 | Renal Failure
on Jun 14, 2010 Male patient from UNITED STATES , 56 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: renal failure. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), POLPRAZOL (View Polprazol Review and Polprazol Label ), DHC CONTINUS (View Dhc Continus Review and Dhc Continus Label ), MEGESTROL ACETATE (View Megestrol Acetate Review and Megestrol Acetate Label ), KETONAL (View Ketonal Review and Ketonal Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ). Patient was hospitalized.

6771410-2 | Cardio-respiratory Arrest, Hypersensitivity, Hypoxia
on Jun 09, 2010 Female patient from AUSTRALIA , 57 years of age, weighting 187.4 lb, was diagnosed with adrenocortical carcinoma, metastasis and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, hypersensitivity, hypoxia. Paclitaxel dosage: 111 Mg Milligram (s), Intravenous. During the same period patient was treated with CARBOPLATIN (150 Mg Milligram (s), Intravenous) (View Carboplatin Review and Carboplatin Label ), GRANISETRON (View Granisetron Review and Granisetron Label ), COLOXYL WITH SENNA (View Coloxyl With Senna Review and Coloxyl With Senna Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6771409-6 | Cardio-respiratory Arrest, Hypersensitivity, Hypoxia
Patient was taking Paclitaxel (View Usage). Patient had the following side effects: cardio-respiratory arrest, hypersensitivity, hypoxia on Jun 09, 2010 from AUSTRALIA Additional patient health information: Female patient , 65 years of age, weighting 154.3 lb, was diagnosed with ovarian cancer and. Paclitaxel dosage: 312 Mg Milligram (s), Intravenous. During the same period patient was treated with CARBOPLATIN (590 Mg Milligram (s), Intravenous) (View Carboplatin Review and Carboplatin Label ), GRANISETRON (View Granisetron Review and Granisetron Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6768357-4 | Failure To Thrive, Pneumothorax
Adverse event was reported on Jun 09, 2010 by a Male patient taking Paclitaxel (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: UNITED STATES , 64 years of age, weighting 112.4 lb, After Paclitaxel was administered, patient had the following side effects: failure to thrive, pneumothorax. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6768168-X | Cardio-respiratory Arrest, Hypersensitivity, Hypoxia
on Jun 03, 2010 Female patient from AUSTRALIA , 57 years of age, weighting 187.4 lb, was diagnosed with adrenocortical carcinoma, metastasis and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, hypersensitivity, hypoxia. Paclitaxel dosage: 111 Mg Milligram(s), Intravenous. During the same period patient was treated with CARBOPLATIN (150 Mg Milligram(s), Intravenous) (View Carboplatin Review and Carboplatin Label ), GRANISETRON (View Granisetron Review and Granisetron Label ), (DEXAMETHASONE) (View (dexamethasone) Review and (dexamethasone) Label ), (COLOXYL WITH SENNA) (View (coloxyl With Senna) Review and (coloxyl With Senna) Label ), FELODIPINE (View Felodipine Review and Felodipine Label ). Patient was hospitalized.

6768167-8 | Cardio-respiratory Arrest, Hypersensitivity, Hypoxia
on Jun 03, 2010 Female patient from AUSTRALIA , 65 years of age, weighting 154.3 lb, was diagnosed with ovarian cancer and was treated with Paclitaxel (View Usage). Patient had the following side effects: cardio-respiratory arrest, hypersensitivity, hypoxia. Paclitaxel dosage: 312 Mg Milligram(s), Intravenous. During the same period patient was treated with CARBOPLATIN (590 Mg Milligram(s), Intravenous) (View Carboplatin Review and Carboplatin Label ), GRANISETRON (View Granisetron Review and Granisetron Label ), (DEXAMETHASONE) (View (dexamethasone) Review and (dexamethasone) Label ). Patient was hospitalized.

6767539-5 | Multi-organ Failure, Neutropenia, Septic Shock
Patient was taking Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: multi-organ failure, neutropenia, septic shock on Jun 09, 2010 from UNITED STATES Additional patient health information: Female patient , 51 years of age, was diagnosed with non-small cell lung cancer, osteoporosis (What is osteoporosis?), ear infection (What is ear infection?), back pain (What is back pain?), depression (What is depression?), cancer pain and. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), RISEDRONATE SODIUM (View Risedronate Sodium Review and Risedronate Sodium Label ), SERETIDE (View Seretide Review and Seretide Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), CYCLOBENZAPRINE (View Cyclobenzaprine Review and Cyclobenzaprine Label ), DULOXETINE HYDROCHLORIDE (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ), PROPACET 100 (View Propacet 100 Review and Propacet 100 Label ). Patient was hospitalized.

6766494-1 | Abdominal Pain Upper, Dyspnoea, Erythema
Adverse event was reported on May 27, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: 306.3 Mg Milligram(s), Intravenous) . Location: ITALY , 49 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, dyspnoea, erythema.

6765906-7 | Acute Respiratory Failure, Hypokalaemia, Pancytopenia, Pleural Effusion
on Jun 01, 2010 Female patient from UNITED STATES , weighting 181.0 lb, was diagnosed with breast cancer metastatic and was treated with Paclitaxel (View Usage). Patient had the following side effects: acute respiratory failure, hypokalaemia, pancytopenia, pleural effusion. Paclitaxel dosage: 116mg Daily-weekly 3-4 Weeks. During the same period patient was treated with SUNITINIB MALATE (View Sunitinib Malate Review and Sunitinib Malate Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

6764327-0 | Arthralgia, Carbon Monoxide Diffusing Capacity Decreased, Dyspnoea, Face Oedema, Fibrosis, Hypersensitivity, Localised Oedema, Microstomia, Oedema Peripheral
on May 24, 2010 Female patient from DENMARK , 52 years of age, was diagnosed with ovarian epithelial cancer and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: arthralgia, carbon monoxide diffusing capacity decreased, dyspnoea, face oedema, fibrosis, hypersensitivity, localised oedema, microstomia, oedema peripheral. Paclitaxel dosage: 175 Mg/m2, Three Times Weekly; Intravenous (not Otherwise Specified). During the same period patient was treated with CARBOPLATIN (CABOPLATIN) (View Carboplatin (caboplatin) Review and Carboplatin (caboplatin) Label ), FETANYL (FENTANYL) (View Fetanyl (fentanyl) Review and Fetanyl (fentanyl) Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), PROPOFOL (View Propofol Review and Propofol Label ), ALFENTANIL (View Alfentanil Review and Alfentanil Label ).

6762025-0 | Nervous System Disorder
Patient was taking Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: nervous system disorder on Jun 04, 2010 from GERMANY Additional patient health information: Female patient , 46 years of age, weighting 282.2 lb, was diagnosed with breast cancer (What is breast cancer?) and. Paclitaxel dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), VOLTAREN (View Voltaren Review and Voltaren Label ).

6761427-6 | Asphyxia, Back Pain, Hypersensitivity, Rash
Adverse event was reported on May 24, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: 140 Mg Milligram(s), Intravenous) . Location: ITALY , 72 years of age, Patient had the following side effects: asphyxia, back pain (What is back pain?), hypersensitivity, rash (What is rash?).

6761425-2 | Anaphylactic Reaction, Dizziness, Dyspnoea, Flushing, Oxygen Saturation Decreased
on May 26, 2010 Female patient from UNITED KINGDOM , 44 years of age, weighting 147.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: anaphylactic reaction, dizziness (What is dizziness?), dyspnoea, flushing, oxygen saturation decreased. Paclitaxel dosage: 136 Mg Milligram(s), Intravenous. During the same period patient was treated with (CETRIZINE) (View (cetrizine) Review and (cetrizine) Label ), CHLORHEXIDINE GLUCONATE (View Chlorhexidine Gluconate Review and Chlorhexidine Gluconate Label ), (CODEINE LINCTUS) (View (codeine Linctus) Review and (codeine Linctus) Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

6759558-X | Cardiac Arrest, Myocardial Infarction
on Jun 01, 2010 Male patient from UNITED STATES , 71 years of age, weighting 350.5 lb, was diagnosed with non-small cell lung cancer, hypertension, back pain (What is back pain?), seasonal allergy and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), myocardial infarction. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), COREG (View Coreg Review and Coreg Label ), PERCOCET (View Percocet Review and Percocet Label ), VALIUM (View Valium Review and Valium Label ), NORCO (View Norco Review and Norco Label ), SINGULAIR (View Singulair Review and Singulair Label ), K DUR (View K-dur Review and K-dur Label ).

6758760-0 | Pneumonitis
Patient was taking Paclitaxel (View Usage). Patient had the following side effects: pneumonitis on May 28, 2010 from JAPAN Additional patient health information: Female patient , weighting 104.7 lb, was diagnosed with breast cancer (What is breast cancer?), hyperlipidaemia, nutritional support (What is nutritional support?), rash (What is rash?), back pain (What is back pain?), hypertension and. Paclitaxel dosage: 80mg/m^2 Days 1,8,15 Of 28 Day Cycle. During the same period patient was treated with FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), ALESION (View Alesion Review and Alesion Label ), LOXOPROFEN SODIUM (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), AZELNIDIPINE (View Azelnidipine Review and Azelnidipine Label ), BETAMETHASONE VALERATE (View Betamethasone Valerate Review and Betamethasone Valerate Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ). Patient was hospitalized.

6756154-5 | Constipation, Nausea, Urinary Tract Infection
Adverse event was reported on Jun 03, 2010 by a Male patient taking Paclitaxel (View Usage) (Dosage: 91 Mg Once Iv) . Location: UNITED STATES , 75 years of age, weighting 182.5 lb, After Paclitaxel was administered, patient had the following side effects: constipation (What is constipation?), nausea (What is nausea?), urinary tract infection (What is urinary tract infection?). During the same period patient was treated with CARBOPLATIN (144 Mg Once Iv) (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6750032-3 | Anaphylactic Reaction, Cardio-respiratory Arrest, Infusion Related Reaction
on May 27, 2010 Female patient from UNITED STATES , weighting 129.0 lb, was diagnosed with lung neoplasm malignant and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, cardio-respiratory arrest, infusion related reaction. Paclitaxel dosage: 50mg/m2 (78mg) Weekly Iv. Patient was hospitalized.

6747201-5 | Cholecystitis
on May 19, 2010 Female patient from UNITED STATES , weighting 172.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Paclitaxel (View Usage). Patient had the following side effects: cholecystitis. Paclitaxel dosage: 148 Mg, Weekly. During the same period patient was treated with SUNITINIB MALATE (12.5 Mg, 2x/day) (View Sunitinib Malate Review and Sunitinib Malate Label ), EFFEXOR (View Effexor Review and Effexor Label ), AMBIEN (View Ambien Review and Ambien Label ), TRAMADOL (View Tramadol Review and Tramadol Label ), COMPAZINE (View Compazine Review and Compazine Label ).

6747112-5 | Acute Respiratory Failure, Breast Cancer Female, Disease Progression, Hypokalaemia, Pancytopenia, Pleural Effusion
Patient was taking Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: acute respiratory failure, breast cancer female, disease progression, hypokalaemia, pancytopenia, pleural effusion on May 18, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 180.8 lb, was diagnosed with breast cancer metastatic and. Paclitaxel dosage: 65mg/m2, Weekly 3 Of 4 Weeks, 116mg, Daily. During the same period patient was treated with SUNITINIB MALATE (37.5 Mg, 1x/day) (View Sunitinib Malate Review and Sunitinib Malate Label ), EFFEXOR XR (75 Mg, 1x/day) (View Effexor Xr Review and Effexor Xr Label ), DOCUSATE SODIUM (5 Mg, 1-2 Daily Prn) (View Docusate Sodium Review and Docusate Sodium Label ), IBUPROFEN (600 Mg, Q 4-6 Hr, Prn) (View Ibuprofen Review and Ibuprofen Label ), AMBIEN (10 Mg, Prn) (View Ambien Review and Ambien Label ), HYDROCHLOROTHIAZIDE (25 Mg, Prn, Daily) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZOMETA (4 Mg, Once A Month, Dose Today 03feb2009) (View Zometa Review and Zometa Label ), CALCIUM (600 Mg, 2x/day) (View Calcium Review and Calcium Label ). Patient was hospitalized.

6746554-1 | Chest Discomfort, Dyspnoea, Hot Flush, Hypersensitivity, Malaise, Rash Pruritic
Adverse event was reported on May 11, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: 390 Mg Milligram(s), Intravenous; 390 Milligram(s); 390 Mg Milligram(s);) . Location: FRANCE , 67 years of age, Patient experienced the following unwanted or unexpected effects: chest discomfort, dyspnoea, hot flush, hypersensitivity, malaise, rash pruritic. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), RANITIDINE HCL (View Ranitidine Hcl Review and Ranitidine Hcl Label ), (POLARAMINE /00043702/) (View (polaramine /00043702/) Review and (polaramine /00043702/) Label ), (KYTRIL /00178101/) (View (kytril /00178101/) Review and (kytril /00178101/) Label ).

6744578-1 | Pneumonitis
on May 24, 2010 Female patient from JAPAN , weighting 104.7 lb, was diagnosed with breast cancer (What is breast cancer?), hyperlipidaemia, nutritional support (What is nutritional support?), rash (What is rash?), back pain (What is back pain?), hypertension and was treated with Paclitaxel (View Usage). Patient had the following side effects: pneumonitis. Paclitaxel dosage: 80mg/m^2 Days 1,8,15 Of 28 Day Cycle. During the same period patient was treated with FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), ALESION (View Alesion Review and Alesion Label ), LOXOPROFEN SODIUM (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), AZELNIDIPINE (View Azelnidipine Review and Azelnidipine Label ), BETAMETHASONE VALERATE (View Betamethasone Valerate Review and Betamethasone Valerate Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ). Patient was hospitalized.

6743121-0 | Liver Injury
on May 14, 2010 Female patient from UNITED KINGDOM , 70 years of age, weighting 114.6 lb, was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: liver injury. Paclitaxel dosage: Intravenous. During the same period patient was treated with CARBOPLATIN (Intravenous) (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6742359-6 | Multi-organ Failure, Neutropenia, Septic Shock
Patient was taking Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure, neutropenia, septic shock on May 20, 2010 from UNITED STATES Additional patient health information: Female patient , 51 years of age, was diagnosed with non-small cell lung cancer, osteoporosis (What is osteoporosis?), ear infection (What is ear infection?), back pain (What is back pain?), depression (What is depression?), cancer pain and. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), RISEDRONATE SODIUM (View Risedronate Sodium Review and Risedronate Sodium Label ), SERETIDE (View Seretide Review and Seretide Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), CYCLOBENZAPRINE (View Cyclobenzaprine Review and Cyclobenzaprine Label ), DULOXETINE HYDROCHLORIDE (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ), PROPACET 100 (View Propacet 100 Review and Propacet 100 Label ). Patient was hospitalized.

6741973-1 | Anaphylactoid Shock, Chest Pain, Tachycardia
Adverse event was reported on May 11, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: 80 Milligrams, Intravenous) was diagnosed with adenocarcinoma pancreas and. Location: FRANCE , 32 years of age, Patient had the following side effects: anaphylactoid shock, chest pain (What is chest pain?), tachycardia. During the same period patient was treated with POLARAMINE (View Polaramine Review and Polaramine Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6739996-1 | Pancreatitis
on May 20, 2010 Male patient from UNITED STATES , 48 years of age, was diagnosed with non-small cell lung cancer, hypertension, hyperglycaemia, hyperlipidaemia, cough and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: pancreatitis. Paclitaxel dosage: Day 1 Of 21 Day Cycle. During the same period patient was treated with CARBOPLATIN (Auc 6 Day 1 Of 21 Day Cycle) (View Carboplatin Review and Carboplatin Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN (View Metformin Review and Metformin Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PROMETHAZINE W/ CODEINE (View Promethazine W/ Codeine Review and Promethazine W/ Codeine Label ), INSULIN (1df=6 Units) (View Insulin Review and Insulin Label ). Patient was hospitalized.

6736301-1 | Morphoea, Oedema Peripheral, Scleroderma
on May 14, 2010 Female patient from JAPAN , 53 years of age, was diagnosed with endometrial cancer and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: morphoea, oedema peripheral, scleroderma (What is scleroderma?). Paclitaxel dosage: 180 Mg/m2. During the same period patient was treated with CARBOPLATIN (Once Every 3 Weeks (received A Total Of 6 Doses)) (View Carboplatin Review and Carboplatin Label ).

6735475-6 | Atrial Fibrillation, Chronic Obstructive Pulmonary Disease, Deep Vein Thrombosis, Pneumonia, Pulmonary Embolism, Renal Failure Acute, Tumour Lysis Syndrome
Patient was taking Paclitaxel (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), chronic obstructive pulmonary disease, deep vein thrombosis (What is deep vein thrombosis?), pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?), renal failure acute, tumour lysis syndrome on May 18, 2010 from UNITED STATES Additional patient health information: Male patient , 68 years of age, weighting 200.6 lb, was diagnosed with non-small cell lung cancer, agitation, prophylaxis, cough, oral pain and. Paclitaxel dosage: Taken Off Study On 29oct09. During the same period patient was treated with CARBOPLATIN (6 Dosageform = 6 Auc Taken Off Study On 29oct09) (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (Taken Off Study On 29oct09) (View Bevacizumab Review and Bevacizumab Label ), HALDOL (View Haldol Review and Haldol Label ), XENADERM (View Xenaderm Review and Xenaderm Label ), ROBITUSSIN (View Robitussin Review and Robitussin Label ), HYDROMET (View Hydromet Review and Hydromet Label ), BENADRYL (View Benadryl Review and Benadryl Label ), MAALOX (View Maalox Review and Maalox Label ). Patient was hospitalized.

6734707-8 | Chest Discomfort, Musculoskeletal Discomfort, Throat Tightness
Adverse event was reported on May 19, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: 120 Mg Weekly Iv Bolus) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 60 years of age, After Paclitaxel was administered, patient had the following side effects: chest discomfort, musculoskeletal discomfort, throat tightness. Patient was hospitalized.

6731404-X | Feeling Abnormal, Flushing, Hypoxia, Syncope, Unresponsive To Stimuli
on May 18, 2010 Male patient from UNITED STATES , 80 years of age, weighting 187.8 lb, was diagnosed with lung neoplasm malignant and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: feeling abnormal, flushing, hypoxia, syncope, unresponsive to stimuli. Paclitaxel dosage: 100 Mg Other Iv. Patient was hospitalized.

6728660-0 | Scleroderma
on May 12, 2010 Female patient from FRANCE , 63 years of age, was diagnosed with malignant peritoneal neoplasm and was treated with Paclitaxel (View Usage). Patient had the following side effects: scleroderma (What is scleroderma?). Paclitaxel dosage: . During the same period patient was treated with PARAPLATIN (View Paraplatin Review and Paraplatin Label ).

6727639-2 | Anaphylactic Reaction, Flushing, Respiratory Failure
Patient was taking Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: anaphylactic reaction, flushing, respiratory failure on Apr 27, 2010 from SPAIN Additional patient health information: Female patient , 65 years of age, was diagnosed with ovarian cancer and. Paclitaxel dosage: .

6725124-5 | Pneumonitis
Adverse event was reported on May 11, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: 80mg/m^2 Days 1,8,15 Of 28 Day Cycle) was diagnosed with breast cancer (What is breast cancer?), hyperlipidaemia, nutritional support (What is nutritional support?), rash (What is rash?), back pain (What is back pain?), hypertension and. Location: JAPAN , weighting 104.7 lb, Patient experienced the following unwanted or unexpected effects: pneumonitis. During the same period patient was treated with FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), ALESION (View Alesion Review and Alesion Label ), LOXOPROFEN SODIUM (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), AZELNIDIPINE (View Azelnidipine Review and Azelnidipine Label ), BETAMETHASONE VALERATE (View Betamethasone Valerate Review and Betamethasone Valerate Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ). Patient was hospitalized.

6720660-X | Systemic Sclerosis
on Apr 28, 2010 Female patient from JAPAN , 53 years of age, was diagnosed with endometrial cancer and was treated with Paclitaxel (View Usage). Patient had the following side effects: systemic sclerosis. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6720010-9 | Pneumonitis
on May 07, 2010 Female patient from JAPAN , weighting 104.7 lb, was diagnosed with breast cancer (What is breast cancer?), hyperlipidaemia, nutritional support (What is nutritional support?), rash (What is rash?), back pain (What is back pain?), hypertension and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: pneumonitis. Paclitaxel dosage: 80mg/m^2 Days 1,8,15 Of 28 Day Cycle. During the same period patient was treated with FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), ALESION (View Alesion Review and Alesion Label ), LOXOPROFEN SODIUM (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), AZELNIDIPINE (View Azelnidipine Review and Azelnidipine Label ), BETAMETHASONE VALERATE (View Betamethasone Valerate Review and Betamethasone Valerate Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ). Patient was hospitalized.

6713671-1 | Chest Discomfort, Flushing, Wheezing
Patient was taking Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort, flushing, wheezing on Apr 28, 2010 from CANADA Additional patient health information: Female patient , 48 years of age, weighting 156.5 lb, . Paclitaxel dosage: 312 Mg,1 Every 14 Days.

6713669-3 | Blood Pressure Abnormal, Circulatory Collapse, Loss Of Consciousness
Adverse event was reported on Apr 23, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: ) . Location: GERMANY , 72 years of age, Patient had the following side effects: blood pressure abnormal, circulatory collapse, loss of consciousness.

6710137-X | Arterial Thrombosis
on Apr 29, 2010 Male patient from UNITED STATES , 68 years of age, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: arterial thrombosis. Paclitaxel dosage: Regimen 2: 643mg, Cyclic Every 3 Weeks, Iv 16feb2009.. During the same period patient was treated with CARBOPLATIN (Cyclic) (View Carboplatin Review and Carboplatin Label ), ASPARGIN (View Aspargin Review and Aspargin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ESSENTIALE (View Essentiale Review and Essentiale Label ), TRIMETAZIDINE (View Trimetazidine Review and Trimetazidine Label ), LORISTA (View Lorista Review and Lorista Label ). Patient was hospitalized.

6709872-9 |
on Apr 29, 2010 Male patient from UNITED STATES , 72 years of age, weighting 147.7 lb, was diagnosed with non-small cell lung cancer and was treated with Paclitaxel (View Usage). . Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6709153-3 | Grand Mal Convulsion, Infusion Related Reaction, Loss Of Consciousness, Respiratory Arrest
Patient was taking Paclitaxel (View Usage). Patient had the following side effects: grand mal convulsion, infusion related reaction, loss of consciousness, respiratory arrest on May 03, 2010 from UNITED STATES Additional patient health information: Male patient , 82 years of age, weighting 225.0 lb, was diagnosed with lung neoplasm malignant and. Paclitaxel dosage: 114 Mg Weekly Iv Drip 1st Dose. During the same period patient was treated with ALOXI (View Aloxi Review and Aloxi Label ), DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).